China’s Basic Health Insurance For Innovative Drugs Needs Reform

Commercial Schemes A New Option

 
• By Xu Hu

China is advocating reforms to health insurance, particularly the wider use of commercial schemes, for reasons to support innovative drug development.

China's health insurance payment method reform
China is reforming its health insurance payment method, especially commercial health insurance. (Shutterstock)
Xu Hu

Read more by Xu Hu

Xu is a senior reporter and covers aspects on policy and regulations in China pharma industry within the APAC Pharma news team.

More from China

More from Market Access